SEC Form 4 · accession 0001179022-19-000015
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Shulman
Director
Period of report
Jan 16, 2019
Accepted (ET)
Jan 18, 2019 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $4.72 | Jan 16, 2019 | A | 25,000 | A | — | Jan 16, 2029 | Common stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The options vest 100% on January 16, 2020.